269 related articles for article (PubMed ID: 19387020)
21. Loss-of-function but not dominant-negative intragenic
Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
[TBL] [Abstract][Full Text] [Related]
22. Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.
Lana T; de Lorenzo P; Bresolin S; Bronzini I; den Boer ML; Cavé H; Froňková E; Stanulla M; Zaliova M; Harrison CJ; de Groot H; Valsecchi MG; Biondi A; Basso G; Cazzaniga G; te Kronnie G
Leukemia; 2015 Oct; 29(10):2107-10. PubMed ID: 25778098
[No Abstract] [Full Text] [Related]
23. Expression of Ikaros isoform 6 in chinese children with acute lymphoblastic leukemia.
Zhou F; Mei H; Jin R; Li X; Chen X
J Pediatr Hematol Oncol; 2011 Aug; 33(6):429-32. PubMed ID: 21792038
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of IKZF1
Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
[TBL] [Abstract][Full Text] [Related]
25. [Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities].
Liu X; Zhang L; Zou Y; Chang L; Wei W; Ruan M; Chen Y; Yang W; Chen X; Guo Y; Wang S; Liu T; Zhang J; Liu F; Qi B; An W; Zhu X
Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):126-30. PubMed ID: 26875463
[TBL] [Abstract][Full Text] [Related]
26. ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
Lo A; Gu G; Liu M; Dev VG
Leuk Res; 2009 Aug; 33(8):e98-103. PubMed ID: 19282030
[No Abstract] [Full Text] [Related]
27. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.
Jia M; Wang ZJ; Li JY; Yang SL; Zhao HZ; Cheng YP; Luo ZB; Tang YM
Cancer Biomark; 2014; 14(6):493-503. PubMed ID: 25335741
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis.
Srinivasan S; Ramanathan S; Kumar S; Peyam S; Radhakrishnan V
Ann Hematol; 2023 Aug; 102(8):2165-2179. PubMed ID: 37154889
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis.
Huang Z; Jia Y; Ruan G; Zuo Y; Wu J; Lu A; Xue Y; Cheng Y; Zhang L
Pediatr Hematol Oncol; 2022 Apr; 39(3):243-253. PubMed ID: 34582325
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.
Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR
BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.
Boer JM; van der Veer A; Rizopoulos D; Fiocco M; Sonneveld E; de Groot-Kruseman HA; Kuiper RP; Hoogerbrugge P; Horstmann M; Zaliova M; Palmi C; Trka J; Fronkova E; Emerenciano M; do Socorro Pombo-de-Oliveira M; Mlynarski W; Szczepanski T; Nebral K; Attarbaschi A; Venn N; Sutton R; Schwab CJ; Enshaei A; Vora A; Stanulla M; Schrappe M; Cazzaniga G; Conter V; Zimmermann M; Moorman AV; Pieters R; den Boer ML
Leukemia; 2016 Jan; 30(1):32-8. PubMed ID: 26202931
[TBL] [Abstract][Full Text] [Related]
32. Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia.
O'Reilly J; Russell LJ; Cooney J; Ensor HM; Purtill D; Wright M; Moorman AV
Pathology; 2013 Oct; 45(6):609-12. PubMed ID: 24018820
[No Abstract] [Full Text] [Related]
33. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650
[TBL] [Abstract][Full Text] [Related]
34. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G
Haematologica; 2008 Dec; 93(12):1814-21. PubMed ID: 18838475
[TBL] [Abstract][Full Text] [Related]
35. Genetic inactivation of Ikaros is a rare event in human T-ALL.
Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
[TBL] [Abstract][Full Text] [Related]
36. Quantitative detection of IKZF1 deletion by digital PCR in patients with acute lymphoblastic leukemia.
Hashiguchi J; Onozawa M; Okada K; Amano T; Hatanaka KC; Nishihara H; Sato N; Teshima T
Int J Lab Hematol; 2019 Apr; 41(2):e38-e40. PubMed ID: 30457697
[No Abstract] [Full Text] [Related]
37. Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.
Dong Y; Liu F; Wu C; Li S; Zhao X; Zhang P; Jiao J; Yu X; Ji Y; Zhang M
Clin Exp Immunol; 2016 Sep; 185(3):320-31. PubMed ID: 27198500
[TBL] [Abstract][Full Text] [Related]
38. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
39. A case of ABL deletion in a patient with precursor B cell lymphoblastic leukemia.
Huh J; Moon H; Chung W
Ann Hematol; 2008 Mar; 87(3):239-41. PubMed ID: 17846770
[No Abstract] [Full Text] [Related]
40. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
